You are the international manager of a U.S. business that has just invented a revolutionary new blood analysis machine that can perform the same functions as traditional lab testing equipment, but costs only half as much to manufacture. Your CEO has asked you to decide how to expand into the European Union market. Your options are

(a) to export from the United States,

(b) to license a European firm to manufacture and market the computer in Europe, and

(c) to set up a wholly owned subsidiary in Europe.

Evaluate the pros and cons of each alternative and suggest a course of action to your CEO.